AI-guided biomanufacturing for personalized regenerative medicine
Cellino builds autonomous manufacturing systems for personalized regenerative medicine. Its technology stack combines deep learning, laser cell management, and closed-loop optical bioprocesses to produce patient-specific cells and tissues, aiming to make autologous iPSC-derived therapies more reproducible and scalable. The company partners with tissue-engineering firms such as Polyphron and publishes at cellinobio.com.